Adicet Bio, Inc. Other Non-Current Liabilities
Adicet Bio, Inc. (ACET) had Other Non-Current Liabilities of $0 as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $0.00.
- 2026-03-31: Other Liabilities, Noncurrent $0.00.
- 2025-12-31: Other Liabilities, Noncurrent $62.00K.
- 2025-09-30: Other Liabilities, Noncurrent $125.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $62.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $125.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $116.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $116.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $116.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $116.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $116.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $116.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $130.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $143.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $130.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $116.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $114.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $116.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $115.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $115.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $115.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $116.00K 10-Q · filed 2021-11-10 |
| 2020-09-30 | $41.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $34.00K 10-Q · filed 2020-07-30 |
| 2020-03-31 | $24.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $15.00K 10-Q · filed 2020-07-30 |
| 2019-09-30 | $6.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $11.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $15.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $19.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $22.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $25.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $28.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |